Clinical and serum digoxin concentration data are presented for five cases of accidental or suicidal ingestion of large amounts of digoxin. Three patients, 20 years of age or less, were without previous evidence of heart disease and responded with the development of atrioventricular block or sino-atrial exit block, which was reversed in two instances by atropine. The third died with refractory hyperkalemia, suggesting generalized inhibition of the cellular sodium-potassium transport system. Ventricular ectopic beats did not occur in any of these three. In contrast, two patients with preexisting advanced coronary artery disease developed multifocal ventricular premature beats, ventricular tachycardia, and ventricular fibrillation as initial manifestations of toxicity.
Serum digoxin levels 4 or more hours after each ingestion were markedly in excess of those ordinarily encountered in patients receiving usual therapeutic doses, reaching levels as high as 42 ng/ml. Apparent serum half-times between 5 and 48 hours after each ingestion were shorter than those usually observed with normal therapeutic doses of digoxin. Blood was obtained for serum digoxin assay by routine venipuncture at the times indicated in table 1 . Following separation of formed elements by centrifugation, serum was assayed in duplicate for digoxin concentration by a sensitive and precise radioimmunoassay method previously de- scribed.6' 7 The serum was diluted when very high concentrations were encountered, in order that the level measured might fall on an optimally sensitive portion of the standard curve. J. F., a 22-year-old boy weighing 37 lb., accidentally ingested 5.75 mg digoxin in the form of 0.25-mg tablets. He was given ipecac within approximately 30 min of the ingestion, and brought to the hospital. There was no previous history of cardiac disease. On initial physical examination he had a blood pressure of 90/60, a regular pulse rate of 85 beats/min, and normal respirations and temperature. The results of the remainder of the physical examination were within normal limits. An ECG taken on admission showed slight sinus arrhythmia. Four hours after admission, intermittent sino-atrial (SA) pauses or, more likely, SA exit block was observed, with probable atrioventricular (A-V) junctional escape beats. Atropine in small doses immediately restored normal sinus rhythm ( fig. 1 ). Electrocardiograms taken 2 hr subsequently demonstrated first degree A-V block followed by 2:1 second degree A-V block. Atropine was not given at this time. Twenty-eight hours after admission stable first degree block was present, soon followed by normal sinus rhythm. Of the five patients reported here, all had blood urea nitrogen or serum creatinine values in the normal range. Three were 20 years of age or less and were without previous evidence of heart disease. In all three, the cardiac response to ingestion of very large doses of digoxin was the development of heart block: high grade A-V block in two instances and first and second degree A-V block in the third. Ventricular premature beats did not occur in any of the three. Two of the three patients survived despite very high serum, and presumably myocardial, levels of digoxin. In one of these patients, atropine reverted significant A-V block to a normal conduction pattern, and sino-atrial exit block was reversed in the other. Thus, despite the well-known extravagal effects of digitalis glycosides on the conducting system,8'0 the therapeutic success of atropine in these obviously toxic patients underscores its potential role in the management of digitalis-induced SA or A-V block. A case similar to our case 1 has been described by Surawicz and Mortelmans, in which atropine abolished depression of SA node activity (or exit block) in a healthy 17-yearold woman following suicidal ingestion of digitoxin."1 It may be that the generally unfavorable experience with atropine in digitalis-induced A-V block reported by some authors'2 is relevant chiefly to situations in which digitalis has been administered chronically to patients with diseased hearts; the cases reported here differ both in the absence of preexisting heart disease and in the acute nature of the toxic insult. The efficacy of atropine in reversing digitalis-induced A-V block has also been noted by Miller. 13 The third patient with no prior history of cardiac disease succumbed with refractory hyperkalemia and high grade A-V block despite the most vigorous and sophisticated supportive efforts. This patient had a serum digoxin level of 42 ng/ml 4 hr after the ingestion, which is the highest level we have observed in over 6000 determinations covering a broad spectrum of clinical circumstances. The occurrence of refractory hyperkalemia in this case is of interest, and suggests that generalized inhibition of the sodium-potassium activated adenosine triphosphatase (ATPase) of the cell membrane may have occurred with this massive dose of cardiac glycoside, resulting in impairment of the ability of cells to maintain the normally high ratio of intracellular to extracellular potassium concentration. 415 Consistent with this hypothesis are the observations of Gaultier et al., 5 who found an elevated mean serum potassium level following acute ingestion of large amounts of cardiac glycosides compared with nondigitalized control subjects; cases with a fatal outcome, in turn, had a higher mean level than that of those patients who survived. Thus, despite its usefulness in many cases of digitalis intoxication characterized by ectopic impulse formation, supplemental potassium may increase A-V block and should not be used as a matter of routine without due consideration of the type of rhythm disturbance, serum potassium concentration, and renal function.'0
The possibility that propoxyphene intoxication played a role in this patient's demise cannot be excluded. Transient QRS widening has been observed in association with seizures, apnea, and cyanosis in a reported case of severe propoxyphene intoxication, but there was no evidence of A-V block or electrolyte disturbance.16 It seems reasonable to presume that the primary clinical problems in this case were directly related to digoxin intoxication.
The remaining two patients exhibited frequent ventricular premature beats with episodic ventricular tachycardia or ventricular fibrillation during the initial 24 hr after ingesting the digoxin. In both instances A-V block appeared after the ventricular excitability had diminished under the influence of antiarrhythmic drugs. Both of the latter two patients had coronary artery disease with previous myocardial infaretions. This experience is consistent with previous observations that the response of the normal human heart to digitalis excess tends to be development of A-V conduction disturbances, while the diseased heart frequently responds with ectopic impulse formation, particularly from ventricular foci.1' 2, 17, 18
An interesting analogy to these observations in normal hearts may be found in pediatric clinical experience, where P-R interval prolongation constitutes a frequent sign of impending digitalis excess and the sudden emergence of ectopic ventricular arrhythmias as a manifestation of digitalis intoxication is uncommon.1'9 20 One may speculate that the absence of coronary artery disease with attendant areas of focal ischemia may be an important factor. The converse of this situation may be reflected in the increased incidence of coronary artery disease among adult patients who exhibit digitalis intoxication at relatively low serum concentrations of digoxin or digitoxin.21 22 The apparent serum half-times for digoxin clearance exhibited by these patients are of interest. The mean serum half-time for orally administered tritiated digoxin following tissue uptake and distribution in subjects with normal renal function is about 31 hr.23 This plateau is reached within about 6 hr after oral doses of digoxin.23 24 Although the data from cases 1, 2, 3, and 4 allow only approximations of serum half-times, the range of values from about 6 to 22 hr for samples drawn 5 or more hr after the ingestion represents a departure from the expected mean. The more detailed data from case 5 (see fig. 4 ) indicate that only after 48 hr, when the serum level has fallen to the usual range encountered in patients on therapeutic doses of digoxin, does the serum half-time reach the expected value of 32 hr. One explanation of these results lies in the possibility that gastrointestinal absorption of these larger doses was slowed, and that tissue uptake and distribution was occurring later than usual. The relatively high level at 13 hr compared with that at 1 hr in case 1 is compatible with a prolonged phase of gastrointestinal absorption. Hence a relatively late Circulation, Voluzme XLIV. July 1971 serum peak with continuing tissue uptake may have combined with renal clearance to shorten the serum half-times in some cases. However, since gut absorption of digoxin appears to be a passive process without evidence of saturation kinetics,25 this mechanism must remain conjectural. Alternatively, it may be that the halftime for tissue uptake and distribution is prolonged with massive doses, independent of the rate of gastrointestinal absorption. Here again, the combined effects of tissue uptake and renal excretion would be operative during the period when renal excretion alone dominates the clearance from the serum of usual doses. Finally, it may be that the relationship between tissue and serum levels is altered with massive ingestions in favor of higher serum: tissue ratios, resulting in a relatively greater proportion of the total body burden of drug being presented to the glomerulus per unit time for filtration and excretion.
The What is now figure 7A should be figure 7B , and what is now figure 7B should be figure 7A. 
